Skip to main content
OpenTrials
Completed

NCT Number: NCT00837798

RATE Registry - Registry of Atrial Tachyarrhythmia/Atrial Fibrillation (AT/AF) Episodes in the Cardiac Rhythm Management (CRM) Device Population

The purpose of this registry is to produce a prospective, outcome-oriented registry to document the prevalence of AT/AF in the CRM population by using the Advanced AT/AF Diagnostics in select SJM devices.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

St Jude Medical

Sylmar, California, 91342, United States

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Patient is implanted with a CRM device
  • Patient has no documented history of AF (3 months prior to enrollment)
  • Patient is >18 years of age
  • Patient has life expectancy of >24 months

Treatment and study plan

CRM Device

Device

Pacemaker, ICD, or CRT device

Primary outcomes

  1. Prevalence of atrial tachycardia and atrial fibrillation in a cardiac rhythm management population

    Time frame: 24 months

Secondary outcomes

  1. Development or exacerbation of HF

    Time frame: 2 years

  2. Development of AF

    Time frame: 2 years

  3. AT/AF burden

    Time frame: 2 years

Sponsors and collaborators

Lead sponsor

Abbott Medical Devices

Industry

Registry information

Official study title

Registry of AT/AF Episodes in the CRM Device Population: RATE Registry

Acronym: RATE

Important dates

Study start
2006
Primary completion
2012
Study completion
2012
First posted
Feb 5, 2009
Registry last updated
Feb 4, 2019

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.